Stockscreener 앱 받기
0.1475
3.15%
-0.0048
시장 영업 전:
.13
-0.0175
-11.86%
Vincerx Pharma Inc 주식(VINC)의 최신 뉴스
Vincerx Pharma enters at-the-market equity offering deal - MSN
Vincerx Pharma enters at-the-market equity offering deal By Investing.com - Investing.com UK
Vincerx Pharma ends sales agreement, approves reverse stock split - MSN
VINC Stock Touches 52-Week Low at $0.17 Amid Market Challenges - Investing.com UK
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders - GlobeNewswire Inc.
Investor law firms question biotech merger's 'fairness' - The Business Journals
What Did We Find About Insider Trading At Vincerx Pharma Inc (NASDAQ: VINC)? - Stocks Register
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders - Stockhouse Publishing
VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc.VINC - Marketscreener.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders - Stockhouse Publishing
Vincerx Pharma Inc (NASDAQ: VINC): On Track To A Higher Share Price - Stocks Register
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerVINC, VCSA, MRNS, MHLD - Markets Insider
VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders - Business Wire
Stock market today: Intrusion surged by 123.33% while Snow Lake Resources plunged by 21.88% in early trading - Business Upturn
Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - MSN
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket - Benzinga
Vincerx Pharma Announces Merger, Leadership Changes, and Financing - TipRanks
Vincerx Pharma To Be Acquired by Private Biotech, Cut Headcount - MarketWatch
Vincerx Pharma enters binding term sheet for merger with Oqory - TipRanks
Psyence Biomed Announces Closing of $2.0 Million Private Placement - The Manila Times
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - GlobeNewswire
VINC Stock Touches 52-Week Low at $0.18 Amid Market Challenges - Investing.com UK
FDA Approvals News Live Feed - StockTitan
Canadian Solar (NASDAQ:CSIQ) Shares Gap Up – Here’s What Happened - Defense World
Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Down Following Analyst Downgrade - Defense World
Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World
WaFd, Inc (NASDAQ:WAFDP) Short Interest Down 23.6% in November - Defense World
Vinci Partners Investments Ltd. (NASDAQ:VINP) Sees Significant Growth in Short Interest - Defense World
Full Stock Market News from 2024-12-14 - StockTitan
Vincerx Pharma announces workforce reduction of 55%, cost-control measures - Yahoo Finance
VINC Stock Touches 52-Week Low at $0.24 Amid Market Challenges - Investing.com UK
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Asianet Newsable
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of Vip943 - Marketscreener.com
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 - GlobeNewswire
Vincerx Pharma Reports Promising Cancer Drug Results, Explores Strategic Options Amid Cost Cuts - StockTitan
DelveInsight Business Research, LLP: Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - finanznachrichten.de
Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine
Vincerx Pharma gets extension to meet Nasdaq listing criteria - Investing.com
Vincerx Pharma gets extension to meet Nasdaq listing criteria By Investing.com - Investing.com UK
Recursion Completes Exscientia Merger, Creates AI Drug Discovery Powerhouse with $20B+ Pipeline - StockTitan
Leerink Partnrs Weighs in on Vincerx Pharma FY2024 Earnings - Defense World
ARMISTICE CAPITAL, LLC Expands Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - Quartz
Prosight Management, LP Reduces Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Reports Q3 2024 Financial Results - TipRanks
Vincerx Pharma Inc reports results for the quarter ended September 30Earnings Summary - XM
4.81%
자본화:
|
볼륨(24시간):